The drug was developed by a German-American company Micromet, Inc. in cooperation with Lonza.
In 2007, Cambrex divested their biologics business to Lonza to focus on small molecule APIs.
The humanitarian engagement of the Novartis Foundation goes back to the 60s, when the Basel companies Ciba, Geigy, Sandoz, Durand&Huguenin, Hoffmann-La Roche and Lonza founded the Basel Foundation for Developing Countries.
Lonza | Lonza Group |